Balazs Halmos, Professor of Medicine at Montefiore Health System, shared on X:
“Just one lazy Summer Friday for a man- what a giant leap for mankind!
Back-to-back pioneering breakthroughs in this week’s NEJM in GI and GU oncology with targeted therapy doubling OS in advanced pancreatic cancer plus IO/ADC combo replacing neoadjuvant chemotherapy for muscle-invasive bladder cancer while reaching a whopping 50%+ path CR!
Oncology continues to be the hottest field as to landing our and even more importantly our patients’ hopes on the Moon!”
You can also read:
FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer
